Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 797 results for "lymphocyte count"

Clinical impact of peripheral lymphocyte counts for metastatic...

Pre-chemotherapeutic factors to assess the prognosis of patients with advanced urothelial carcinoma have not yet been completely established. Bladder Cancer Diagnosis Muscle Invasive / Metatastic Staging Pathology Guidelines ... UroToday, 1 week ago

CD4 T-Lymphocyte Percentages Corresponding to CD4 T-Lymphocyte Count Thresholds in a New Staging System for HIV Infection

JAIDS Journal of Acquired Immune Deficiency Syndromes. 66(4):e92-e94, August 1, 2014. Email to a Colleague Colleague's E-mail is Invalid Your Name: (optional) Your Email: Colleague's Email: Separate multiple e-mails with a (;). ...
 JAIDS4 weeks ago

Amgen: Grappling With The Reality Of Patent Expiries

Summary Amgen has been recently awarded the breakthrough status for its new drug to treat adults with acute lymphoblastic leukemia. The prevalence rate is quite high, with limited treatment options available. If authorized, Amgen can exploit the ...
 Seeking Alpha4 days ago
Reuters

Record-Breaking Year for The Leukemia & Lymphoma Society's Man & Woman of the Year campaign

-COMMUNITY LEADERS RAISED $30.5 MILLION TO HELP FIND CANCER CURES- PR Newswire WHITE PLAINS, N.Y., July 17, 2014 WHITE PLAINS, N.Y., July 17, 2014 /PRNewswire/ -- A Chicago man and Los Angeles woman raised $386,284 and $343,962, ...
 Reuters5 days ago
[x]  

New Summary: Chronic lymphocytic leukemia. [CancerControl Alberta]

Guideline Title Chronic lymphocytic leukemia. Bibliographic Source(s) ...
 National Guideline Clearinghouse1 week ago Navidea Biopharmaceuticals' (NAVB) CEO Michael Goldberg on Investor Briefing on Sentinel Lymph Node Biopsy in Head & Neck Cancers (Transcript)  Seeking Alpha2 weeks ago Updated Summary: Lymphoma. [CancerControl Alberta]  National Guideline Clearinghouse4 weeks ago Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia  New England Journal of Medicine1 month ago

Anakinra for Secondary Hemophagocytic Lymphohistiocytosis

Surender Rajasekaran, MD, MPH, Katherine Kruse, MD, Karen Kovey, PharmD, Alan T. Davis, PhD, Nabil E. Hassan, MD, Akunne N. Ndika, MBBS, MPH, Sandra Zuiderveen, BSN, RN, James Birmingham, MD Disclosures Pediatr Crit Care ...
 General Medicine eJournal3 weeks ago
Laboratory Network

Validation Study Of The Vi-CELL XR For Automated Cell Counting Of Dendritic Cells

By Iveta Bottova, PhD Dendritic cells (DC) population is a key functional constituent of cell based immunotherapy drugs. The correct cell count and adequate viability of DC are one of the quality control criteria for the final product release.
 Laboratory Network1 month ago

AbbVie releases interim results from Phase Ib trial of ABT-199/GDC-0199

AbbVie released interim results from a Phase Ib clinical trial of ABT-199/GDC-0199, an investigational B-cell lymphoma 2, BCL-2, selective inhibitor, in combination with rituximab. Results showed an overall response rate, ORR, of 84%, in patients ...
 Yahoo! Finance1 month ago AbbVie Presents New Results from Studies of Investigational Oncology Compound ABT-199/GDC-0199 at the 2014 American Society of Clinical Oncology...  Pharmacy Choice1 month ago ABBVIE : Presents New Results from Studies of Investigational Oncology Compound ABT-199/GDC-0199 at the 2014 American Society of Clinical Oncology Annual Meeting  4 Traders1 month ago
[x]  
Scottrade

Ibrutinib (IMBRUVICA®) Three Year Follow-up of Single-Agent and Combination Study Results in Chronic Lymphocytic Leukemia

/PRNewswire/ -- Three year follow-up data from the Phase 1b/2 PCYC-1102 trial of single-agent ibrutinib (IMBRUVICA) suggest continued durable responses in patients with treatment-naive (TN) or relapsed or refractory chronic lymphocytic leukemia ...
 BusinessWeek1 month ago Ibrutinib (IMBRUVICA?) Three Year Follow-up of Single-Agent and Combination Study Results in Chronic Lymphocytic Leukemia  Applied Clinical Trials1 month ago Ibrutinib (IMBRUVICA??) Three Year Follow-up of Single-Agent and Combination Study Results in Chronic Lymphocytic Leukemia  Review Seeker1 month ago Ibrutinib (IMBRUVICA(r)) Three Year Follow-up of Single-Agent and Combination  Finwin1 month ago
[x]  
Seeking Alpha

TG Therapeutics' Novel Combination of TG-1101 (Ublituximab) and TGR-1202 Demonstrates Compelling Early …

100% of CLL/SLL patients had significant nodal reduction with either a normalization of or >=80% reduction in Blood Lymphocyte Count 4 of 5 CLL/SLL patients achieved a partial response at first assessment, including a patient relapsed from a prior ...
 Yahoo! Finance1 day ago Initial Treatment with VELCADE® Improves Outcomes of Patients with Mantle Cell Lymphoma  CancerConnect.com1 week ago Combo therapy demonstrates compelling clinical activity in chronic lymphocytic leukemia and mantle cell lymphoma  Drug Discovery News1 month ago TG Therapeutics' TG-1101 (Ublituximab) in Combination With Ibrutinib Demonstrates Compelling Clinical Activity and Safety Profile in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)  Street Sweeper1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less